Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

Fig. 3

Summary of the odds radios of all outcomes. Major cardiovascular events were defined as a composite, including fatal or non-fatal myocardial infarction, fatal or non-fatal stroke, coronary artery revascularization, and cardiovascular death. Kidney failure events were defined as more than 25% or 50% decrease in eGFR, doubling of serum creatinine, or end-stage renal disease (ESRD). N number of trials

Back to article page